Favre, L.Borle, F.Velin, D.Bachmann, D.Bouzourene, H.Wagnières, G.van den Bergh, H.Ballabeni, P.Gabrecht, T.Michetti, P.Schreiber, S.Ortner, M.-A.2011-06-012011-06-012011-06-01201110.1055/s-0030-1256382https://infoscience.epfl.ch/handle/20.500.14299/68079WOS:000293393600008Background and study aims: Low dose photodynamic therapy (LDPDT) may modify the mucosal immune response and may thus provide a therapy for Crohn's disease. We evaluated the efficacy and safety of this technique in a murine T cell-mediated colitis model.Inflammatory-Bowel-DiseaseDependent Experimental ColitisAdjuvant-Enhanced ArthritisDelta-Aminolevulinic-AcidCrohns-DiseaseBarretts-EsophagusLight DosimetryScid MiceApoptosisLymphocytestext::journal::journal article::research article